Related Experiment Video
Updated: Feb 8, 2026

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60
Published on: December 7, 2017
Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3
Jaewon J Lee1,2, Robert A H van de Ven1,2, Elma Zaganjor1,2
1Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
Abstract:
Metastasis remains the leading cause of cancer mortality, and reactive oxygen species (ROS) signaling promotes the metastatic cascade. However, the molecular pathways that control ROS signaling relevant to metastasis are little studied. Here, we identify SIRT3, a mitochondrial deacetylase, as a regulator of cell migration via its control of ROS signaling. We find that, although mitochondria are present at the leading edge of migrating cells, SIRT3 expression is down-regulated during migration, resulting in elevated ROS levels. This SIRT3-mediated control of ROS represses Src oxidation and attenuates focal adhesion kinase (FAK) activation. SIRT3 overexpression inhibits migration and metastasis in breast cancer cells. Finally, in human breast cancers, SIRT3 expression is inversely correlated with metastatic outcome and Src/FAK signaling. Our results reveal a role for SIRT3 in cell migration, with important implications for breast cancer progression.
Insights
SIRT3, a mitochondrial deacetylase, regulates cancer cell migration by controlling reactive oxygen species (ROS). Down-regulation of SIRT3 increases ROS, promoting metastasis. Overexpression inhibits migration and progression in breast cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Mitochondrial Biology
Background:
- Metastasis is the primary cause of cancer mortality.
- Reactive oxygen species (ROS) signaling is implicated in promoting cancer metastasis.
- Molecular pathways controlling ROS in metastasis are not well understood.
Purpose of the Study:
- To identify molecular regulators of ROS signaling in cancer cell migration.
- To investigate the role of SIRT3 in controlling ROS and cell migration.
- To explore the implications of SIRT3 in breast cancer metastasis.
Main Methods:
- Investigated SIRT3 expression during cell migration.
- Assessed ROS levels in migrating cells.
- Examined the effects of SIRT3 modulation on Src oxidation and focal adhesion kinase (FAK) activation.
- Correlated SIRT3 expression with metastatic outcome in human breast cancers.
Main Results:
- SIRT3 expression is down-regulated during cell migration, leading to increased ROS.
- Elevated ROS due to SIRT3 down-regulation represses Src oxidation and attenuates FAK activation.
- SIRT3 overexpression inhibits breast cancer cell migration and metastasis.
- Human breast cancers show an inverse correlation between SIRT3 expression and metastatic outcome/Src/FAK signaling.
Conclusions:
- SIRT3 acts as a key regulator of cell migration through its control of ROS signaling.
- SIRT3 plays a significant role in suppressing breast cancer progression and metastasis.
- Targeting SIRT3 may offer therapeutic strategies for reducing cancer mortality.
More Related Videos
Related Concept Videos
Cell Migration
Cell Migration
What is Cell Signaling?
Feedback Inhibition
Cell-surface Signaling
Cancer Cell Migration through Invadopodia

